Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bodystat is a private medical device company focused on bioelectrical impedance analysis technologies for non-invasive measurement of body composition, hydration, nutritional status, and cellular health. The company develops and markets portable body composition analyzers and related software used across clinical care, research, and fitness settings. Its products are positioned for applications including fluid management, malnutrition monitoring, renal and dialysis-related assessment, and longitudinal body composition tracking. Bodystat emphasizes medically graded electrodes, reproducibility, and validation against reference methods such as DXA and hydrostatic weighing. The company appears to operate from the Isle of Man and sells internationally through distributors and direct channels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bodystat.